Short Interest in Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) Drops By 45.5%

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) was the target of a large decline in short interest in the month of February. As of February 15th, there was short interest totalling 3,600 shares, a decline of 45.5% from the January 31st total of 6,600 shares. Based on an average daily volume of 37,500 shares, the days-to-cover ratio is presently 0.1 days.

Reviva Pharmaceuticals Stock Performance

RVPHW stock traded up $0.00 during mid-day trading on Friday, hitting $0.13. 2,558 shares of the company were exchanged, compared to its average volume of 26,348. Reviva Pharmaceuticals has a 1-year low of $0.07 and a 1-year high of $0.85. The firm’s 50 day simple moving average is $0.18 and its 200 day simple moving average is $0.16.

Reviva Pharmaceuticals Company Profile

Reviva Pharmaceuticals Holdings, Inc, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis.